FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alessandro Armuzzi

Research Profile

Living Beings

Helicobacter pylori

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
G Andrisani; D Cervelli; Luisa Guidi; Alfredo Papa; Angelo Eugenio Potenza; Alessandro Armuzzi
A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery.
Gianluca Andrisani; Alessandro Armuzzi
Reply to Dr. Joob et al.'s letter.
G Andrisani; Alessandro Armuzzi; B B Blomberg; Italo De Vitis; C Felice; D Frasca; M Marzo; G Mocci; Alfredo Papa; D Pugliese; G L Rapaccini; M Romero; Luisa Guidi
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressants.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alessandro Armuzzi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: G Andrisani; D Cervelli; Luisa Guidi; Alfredo Papa; Angelo Eugenio Potenza; Alessandro Armuzzi
A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery.
Journal of Crohn's & colitis 2013;7(5):421-6.
2013: Gianluca Andrisani; Alessandro Armuzzi
Reply to Dr. Joob et al.'s letter.
Journal of Crohn's & colitis 2013;7(4):e154.
2013: G Andrisani; Alessandro Armuzzi; B B Blomberg; Italo De Vitis; C Felice; D Frasca; M Marzo; G Mocci; Alfredo Papa; D Pugliese; G L Rapaccini; M Romero; Luisa Guidi
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressants.
Journal of Crohn's & colitis 2013;7(4):301-7.
2013: Alessandro Armuzzi; Silvio Danese; Italo De Vitis; Carla Felice; Gionata Fiorino; Manuela Marzo; Alfredo Papa; Daniela Pugliese; Gian Lodovico Rapaccini; Gianluca Rizzo; Orsola Sociale; Gialuca Andrisani; Luisa Guidi
Infliximab in steroid-dependent ulcerative colitis: effectiveness and predictors of clinical and endoscopic remission.
Inflammatory bowel diseases 2013;19(5):1065-72.
2013: Gianluca Andrisani; Alessandro Armuzzi; Italo De Vitis; Carla Felice; Manuela Marzo; Alfredo Papa; Daniela Pugliese; Gian Lodovico Rapaccini; Luisa Guidi
Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients.
Journal of gastrointestinal and liver diseases : JGLD 2013;22(1):21-5.
2013: Alfredo Papa; Daniela Pugliese; Gian Lodovico Rapaccini; Manuela Marzo; Giammarco Mocci; Gianluca Andrisani; Alessandro Armuzzi; Marcello Covino; Italo De Vitis; Carla Felice; Antonio Gasbarrini; Luisa Guidi
Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents.
Journal of Crohn's & colitis 2013;7(2):113-9.
2013: Alessandro Armuzzi; Carla Felice
Inducing remission of ulcerative colitis: are clinicians better equipped than ever?
Expert review of gastroenterology & hepatology 2013;7(2):95-7.
2013: Alessandro Armuzzi; Olga Maria Nardone; Daniela Pugliese; Luisa Guidi
Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab.
Drug design, development and therapy 2013;7():289-96.
2012: G Andrisani; Luisa Guidi; Alfredo Papa; Alessandro Armuzzi
Anti-TNF alpha therapy in the management of extraintestinal manifestation of inflammatory bowel disease.
European review for medical and pharmacological sciences 2012;16(7):890-901.
2012: Antonio De Franco; Carla Felice; Alessandro Armuzzi; Lorenzo Bonomo; Manuela Marzo; Daniela Pugliese; Alessandra Di Veronica; Luisa Guidi
Ileal Crohn's disease: CEUS determination of activity.
Abdominal imaging 2012;37(3):359-68.
2012: Alessandro Armuzzi; Anne Griffiths; Milan Lukas; Guillaume Pineton de Chambrun; Jan C Preiss; Walter Reinisch; Malgorzata Sladek; Gert Van Assche; Geert D'Haens
Results of the 2nd scientific workshop of the ECCO (IV): therapeutic strategies to enhance intestinal healing in inflammatory bowel disease.
Journal of Crohn's & colitis 2012;6(4):492-502.
2012: Antonio De Franco; B De Pascalis; Italo De Vitis; Alessandra Di Veronica; Alessandro Armuzzi; Enrico Bock; Lorenzo Bonomo; Francesco M Danza; Manuela Marzo; Alfredo Papa; Italia Roberto; Luisa Guidi
Ileal Crohn disease: mural microvascularity quantified with contrast-enhanced US correlates with disease activity.
Radiology 2012;262(2):680-8.
2012: Pietro Manuel Ferraro; Luisa Guidi; Pierenrico Lecis; Annalisa Aratari; Alessandro Armuzzi; Marco Astegiano; Giampaolo Bresci; Elisabetta Colombo; Francesco Costa; Roberto de Franchis; Vincenza Di Leo; Renata D'Inca'; V D'Ovidio; Beatrice Principi; Giuseppe Repaci; Chiara Ricci; Gabriele Riegler; Michele Silla; Roberto Testa; Daniela Valpiani; Maurizio Vecchi; Stefano Passalacqua
[Predictors of clinical response in patients with ulcerative colitis treated with granulocyte-monocyte apheresis: analysis of the apheresis registry data].
Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia 2012;29 Suppl 54():S144-6.
2011: Gianluca Rizzo; Alessandro Verbo; Alessandro Armuzzi; Luisa Guidi; Claudio Mattana; Alfredo Papa; Daniela Pugliese; Gian Lodovico Rapaccini; Claudio Coco
Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience.
International journal of colorectal disease 2011;26(11):1435-44.
2011: Alessandro Armuzzi; Daniela Pugliese
IBD: Adalimumab for ulcerative colitis— is the glass half empty or half full?
Nature reviews. Gastroenterology & hepatology 2011;8(5):249-51.
2011: Luisa Guidi; Daniela Pugliese; Alessandro Armuzzi
Update on the management of inflammatory bowel disease: specific role of adalimumab.
Clinical and experimental gastroenterology 2011;4():163-72.
2011: Mario Cottone; Anna Kohn; Marco Daperno; Alessandro Armuzzi; Luisa Guidi; Renata D'inca; Fabrizio Bossa; Erika Angelucci; Livia Biancone; Paolo Gionchetti; Sandro Ardizzone; Claudio Papi; Walter Fries; Silvio Danese; Gabriele Riegler; Maria Cappello; Fabiana Castiglione; Vito Annese; Ambrogio Orlando
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2011;9(1):30-5.
2011: Ambrogio Orlando; Alessandro Armuzzi; Claudio Papi; Vito Annese; Sandro Ardizzone; Livia Biancone; Aurora Bortoli; Fabiana Castiglione; Renata D'Incà; Paolo Gionchetti; Anna Kohn; Gilberto Poggioli; Fernando Rizzello; Maurizio Vecchi; Mario Cottone
The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2011;43(1):1-20.
2010: Veruscka Leso; Lorenzo Leggio; Alessandro Armuzzi; Giovanni Gasbarrini; Antonio Gasbarrini; Giovanni Addolorato
Role of the tumor necrosis factor antagonists in the treatment of inflammatory bowel disease: an update.
European journal of gastroenterology & hepatology 2010;22(7):779-86.
2010: Luisa Guidi; M Marzo; C Felice; G Mocci; L Sparano; D Pugliese; Italo De Vitis; Alfredo Papa; Alessandro Armuzzi
New biological agents for the treatment of the "high risk" IBD patients.
European review for medical and pharmacological sciences 2010;14(4):342-6.
2008: Silvio Danese; Filippo Mocciaro; Luisa Guidi; Maria Lia Scribano; Michele Comberlato; Vito Annese; Elisabetta Colombo; Tommaso Stefanelli; Manuela Marzo; Marcello Vangeli; Raffaella Pulitano'; Aldo Manca; Alessandro Armuzzi; Alberto Malesci; Cosimo Prantera; Mario Cottone
Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use.
Inflammatory bowel diseases 2008;14(8):1168-70.
2008: Marcello Candelli; Luca Miele; Alessandro Armuzzi; Enrico C Nista; Giulia Pignataro; Lucia Fini; Immacolata A Cazzato; Maria Assunta Zocco; F Bartolozzi; Giovanni Gasbarrini; Antonio Grieco; antonio gasbarrini
13C-methionine breath tests for mitochondrial liver function assessment.
European review for medical and pharmacological sciences 2008;12(4):245-9.
2008: Alessandro Armuzzi; B De Pascalis; Paolo Fedeli; F De Vincentis; antonio gasbarrini
Infliximab in Crohn's disease: early and long-term treatment.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2008;40 Suppl 2():S271-9.
2007: Marcello Candelli; Alessandro Armuzzi; Luca Miele; Enrico C Nista; Giulia Pignataro; Lorenzo Zileri Dal Verme; Antonio Grieco; Giovanni Gasbarrini; antonio gasbarrini
Gender affects 13C-ketoisocaproic acid breath test.
European review for medical and pharmacological sciences 2007;11(6):401-6.
2007: Massimo Montalto; Valentina Curigliano; Luca Santoro; Alessandro Armuzzi; Giovanni Cammarota; Marcello Covino; Maria C Mentella; Francesca Ancarani; Raffaele Manna; antonio gasbarrini; Giovanni Gasbarrini
Fecal calprotectin in first-degree relatives of patients with ulcerative colitis.
The American journal of gastroenterology 2007;102(1):132-6.
2006: Silvio Danese; Stefano Semeraro; Alessandro Armuzzi; Alfredo Papa; antonio gasbarrini
Biological therapies for inflammatory bowel disease: research drives clinics.
Mini reviews in medicinal chemistry 2006;6(7):771-84.
2006: Maria Assunta Zocco; L Zileri dal Verme; Filippo Cremonini; Anna Chiara Piscaglia; Enrico C Nista; Marcello Candelli; Marialuisa Novi; Donato Rigante; Immacolata A Cazzato; Veronica Ojetti; Alessandro Armuzzi; Giovanni Gasbarrini; antonio gasbarrini
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis.
Alimentary pharmacology & therapeutics 2006;23(11):1567-74.
2006: Luisa Guidi; A De Franco; Italo De Vitis; Alessandro Armuzzi; Stefano Semeraro; Italia Roberto; Alfredo Papa; E Bock; Giovanni Gasbarrini; Giuseppe Fedeli
Contrast-enhanced ultrasonography with SonoVue after infliximab therapy in Crohn's disease.
European review for medical and pharmacological sciences 2006;10(1):23-6.
2006: B De Pascalis; Antonio Bianchi; M A Satta; Andrea Lupascu; Maria C Mentella; Diego Leo; F Fiore; Paolo Fedeli; Alfredo Pontecorvi; Paolo Pola; Domenico Melina; antonio gasbarrini; Laura De Marinis; Alessandro Armuzzi
Growth hormone in inflammatory bowel disease.
European review for medical and pharmacological sciences 2006;10(1):13-6.
2006: Silvio Danese; Alfredo Papa; Franco Scaldaferri; Cristina Graziani; M Bonizzi; Alessandro Armuzzi; Giuseppe Fedeli; Giovanni Gasbarrini; antonio gasbarrini
A novel pathogenic role for microvasculature in inflammatory bowel disease.
European review for medical and pharmacological sciences 2006;10(1):3-5.
2005: Silvio Danese; Stefano Semeraro; M Marini; Italia Roberto; Alessandro Armuzzi; Alfredo Papa; antonio gasbarrini
Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2005;37(11):811-8.
2005: Filippo Cremonini; Francesco Bartolozzi; Alessandro Armuzzi; Maria Assunta Zocco; Luca Santarelli; Maurizio Gabrielli; Marcello Candelli; Enrico C Nista; Angelo Santoliquido; antonio gasbarrini
Can 13C urea breath test predict resistance to therapy in Helicobacter pylori infection?
Hepato-gastroenterology 2005;52(64):1119-21.
2004: Alessandro Armuzzi; B De Pascalis; Andrea Lupascu; Paolo Fedeli; Diego Leo; Maria C Mentella; F Vincenti; Domenico Melina; Giovanni Gasbarrini; Paolo Pola; antonio gasbarrini
Infliximab in the treatment of steroid-dependent ulcerative colitis.
European review for medical and pharmacological sciences 2004;8(5):231-3.
2004: Alfredo Papa; Roberto Pola; Andrea Flex; Silvio Danese; Alessandro Armuzzi; Eleonora Gaetani; Luisa Guidi; Italo De Vitis; R Urgesi; Antonino Grillo; Michele Serricchio; Anna S Proia; Giuseppe Fedeli; Giovanni Gasbarrini; Paolo Pola; antonio gasbarrini
Prevalence of the K469E polymorphism of intercellular adhesion molecule 1 gene in Italian patients with inflammatory bowel disease.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2004;36(8):528-32.
2004: Andrea Lupascu; Alessandro Armuzzi; B De Pascalis; Emilia Carloni; Ernesto Cristiano Lauritano; antonio gasbarrini; Paolo Pola; A Gasbarrini
Sacroileitis and peripheral arthropathy associated with ulcerative colitis: effect of infliximab on both articular and intestinal symptoms.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2004;36(6):423-5.
2004: Jin Hong Low; Fiona A Williams; Xuesong Yang; Sue Cullen; James Colley; Khoon-Lin Ling; Alessandro Armuzzi; Tariq Ahmad; Matt J Neville; Bryan M Dechairo; Robert Walton; Nicholas J Lench; Derek P Jewell
Inflammatory bowel disease is linked to 19p13 and associated with ICAM-1.
Inflammatory bowel diseases 2004;10(3):173-81.
2004: Marcello Candelli; Alessandro Armuzzi; Enrico C Nista; Lucia Fini; Giovanni Gasbarrini; antonio gasbarrini
13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation.
Alimentary pharmacology & therapeutics 2004;19(2):243.
2004: Enrico C Nista; Lucia Fini; Alessandro Armuzzi; Marcello Candelli; Maria Assunta Zocco; Immacolata A Cazzato; G Merra; Rosalba Finizio; L Miele; A Grieco; Giovanni Gasbarrini; antonio gasbarrini
13C-breath tests in the study of microsomal liver function.
European review for medical and pharmacological sciences 2004;8(1):33-46.
2004: Marcello Candelli; Immacolata A Cazzato; Maria Assunta Zocco; Enrico C Nista; Lucia Fini; Alessandro Armuzzi; V Camise; M Santoro; L Miele; A Grieco; Giovanni Gasbarrini; antonio gasbarrini
13C-breath tests in the study of mitochondrial liver function.
European review for medical and pharmacological sciences 2004;8(1):23-31.
2003: Tariq Ahmad; Alessandro Armuzzi; Matt J Neville; Mike Bunce; Khoon-Lin Ling; Ken I Welsh; Sara E Marshall; Derek P Jewell
The contribution of human leucocyte antigen complex genes to disease phenotype in ulcerative colitis.
Tissue antigens 2003;62(6):527-35.
2003: Luca Miele; Antonio Grieco; Alessandro Armuzzi; Marcello Candelli; Alessandra Forgione; antonio gasbarrini; Giovanni Gasbarrini
Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test.
The American journal of gastroenterology 2003;98(10):2335-6.
2003: A Papa; S Danese; Alessandro Armuzzi; Eleonora Gaetani; Andrea Flex; P Pola; antonio gasbarrini
Association between K469E allele of intercellular adhesion molecule 1 gene and inflammatory bowel disease in different populations.
Gut 2003;52(8):1227-8; author reply 1228.
2003: Alessandro Armuzzi; Tariq Ahmad; Khoon-Lin Ling; A de Silva; Sue Cullen; David A van Heel; Timothy R Orchard; Ken I Welsh; Sara E Marshall; Derek P Jewell
Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31.
Gut 2003;52(8):1133-9.
2003: Cristiana Di Campli; Giuseppina Angelini; Alessandro Armuzzi; Bruno Nardo; Maria Assunta Zocco; Marcello Candelli; Angelo Santoliquido; Antonino Cavallari; Mauro Bernardi; antonio gasbarrini
Quantitative evaluation of liver function by the methionine and aminopyrine breath tests in the early stages of liver transplantation.
European journal of gastroenterology & hepatology 2003;15(7):727-32.
2003: Marcello Candelli; Alfredo Papa; Enrico C Nista; Silvio Danese; Alessandro Armuzzi; Francesco Bartolozzi; Paolo Tondi; Veronica Ojetti; Giovanni Gasbarrini; antonio gasbarrini
Antibodies to Saccharomyces cerevisiae: are they useful in clinical practice?
Hepato-gastroenterology 2003;50(51):718-20.
2003: Tariq Ahmad; Matt J Neville; Sara E Marshall; Alessandro Armuzzi; Kim Mulcahy-Hawes; Jonathan Crawshaw; Hiroe Sato; Khoon-Lin Ling; M C N M Barnardo; Sue Goldthorpe; Robert Walton; Mike Bunce; Derek P Jewell; Ken I Welsh
Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC.
Human molecular genetics 2003;12(6):647-56.
2003: Tariq Ahmad; Graham R Wallace; Teifi James; Matt J Neville; Mike Bunce; Kim Mulcahy-Hawes; Alessandro Armuzzi; Jonathan Crawshaw; Farida Fortune; Robert Walton; Miles R Stanford; Ken I Welsh; Sara E Marshall; Derek P Jewell
Mapping the HLA association in Behçet's disease: a role for tumor necrosis factor polymorphisms?
Arthritis and rheumatism 2003;48(3):807-13.
2003: Antonio Gasbarrini; Veronica Ojetti; Lucio Cuoco; Giovanni Cammarota; Alessio Migneco; Alessandro Armuzzi; Paolo Pola; Giovanni Gasbarrini
Lack of endoscopic visualization of intestinal villi with the "immersion technique" in overt atrophic celiac disease.
Gastrointestinal endoscopy 2003;57(3):348-51.
2003: Rachele Ciccocioppo; M Candelli; D Di Francesco; F Ciocca; Giuliana Taglieri; Alessandro Armuzzi; Giovanni Gasbarrini; A Gasbarrini
Study of liver function in healthy elderly subjects using the 13C-methacetin breath test.
Alimentary pharmacology & therapeutics 2003;17(2):271-7.
2003: Marcello Candelli; Enrico C Nista; Manuela Nestola; Alessandro Armuzzi; Nicolò Gentiloni Silveri; Giovanni Gasbarrini; antonio gasbarrini
Saccharomyces cerevisiae-associated diarrhea in an immunocompetent patient with ulcerative colitis.
Journal of clinical gastroenterology 2003;36(1):39-40.
2002: Simona Di Caro; Maria Assunta Zocco; Filippo Cremonini; Marcello Candelli; Enrico C Nista; Francesco Bartolozzi; Alessandro Armuzzi; Giovanni Cammarota; Luca Santarelli; Antonio Gasbarrini
Levofloxacin based regimens for the eradication of Helicobacter pylori.
European journal of gastroenterology & hepatology 2002;14(12):1309-12.
2002: Alessandro Armuzzi; Marcello Candelli; Maria Assunta Zocco; A Andreoli; Antonino De Lorenzo; Enrico C Nista; L Miele; Filippo Cremonini; Immacolata A Cazzato; A Grieco; Giovanni Gasbarrini; antonio gasbarrini
Review article: breath testing for human liver function assessment.
Alimentary pharmacology & therapeutics 2002;16(12):1977-96.
2002: Filippo Cremonini; Simona Di Caro; Marcello Covino; Alessandro Armuzzi; Maurizio Gabrielli; Luca Santarelli; Enrico C Nista; Giovanni Cammarota; Giovanni Gasbarrini; antonio gasbarrini
Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study.
The American journal of gastroenterology 2002;97(11):2744-9.
2002: Filippo Canducci; Filippo Cremonini; Alessandro Armuzzi; Simona Di Caro; Maurizio Gabrielli; Luca Santarelli; Enrico C Nista; Andrea Lupascu; D De Martini; antonio gasbarrini
Probiotics and Helicobacter pylori eradication.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2002;34 Suppl 2():S81-3.
2002: Tariq Ahmad; Sara E Marshall; Kim Mulcahy-Hawes; T Orchard; Jonathan Crawshaw; Alessandro Armuzzi; Matt J Neville; David A van Heel; M C N M Barnardo; Ken I Welsh; Derek P Jewell; Mike Bunce
High resolution MIC genotyping: design and application to the investigation of inflammatory bowel disease susceptibility.
Tissue antigens 2002;60(2):164-79.
2002: Francesco Franceschi; Alessandro Armuzzi; Filippo Cremonini; Emilia Carloni; Maria Assunta Zocco; Simona Di Caro; Cristiano Padalino; Robert Genta; Paolo Pola; Giovanni Gasbarrini; antonio gasbarrini
Delta13CO2 excretion and expression of dyspeptic symptoms in patients evaluated for Helicobacter pylori infection by [13C] urea breath test.
Digestive diseases and sciences 2002;47(4):804-8.
2002: Tariq Ahmad; Alessandro Armuzzi; Mike Bunce; Kim Mulcahy-Hawes; Sara E Marshall; Timothy R Orchard; Jonathan Crawshaw; Oliver Large; Arjuna de Silva; Julia T Cook; M C N M Barnardo; Sue Cullen; Ken I Welsh; Derek P Jewell
The molecular classification of the clinical manifestations of Crohn's disease.
Gastroenterology 2002;122(4):854-66.
2001: Veronica Ojetti; Alessandro Armuzzi; A De Luca; Eleonora Nucera; Francesco Franceschi; Marcello Candelli; G F Zannoni; S Danese; Simona Di Caro; Monica Vastola; Domenico Schiavino; Giovanni Gasbarrini; Giampiero Patriarca; Paolo Pola; antonio gasbarrini
Helicobacter pylori infection affects eosinophilic cationic protein in the gastric juice of patients with idiopathic chronic urticaria.
International archives of allergy and immunology 2001;125(1):66-72.
2001: S Danese; Filippo Cremonini; Alessandro Armuzzi; Marcello Candelli; Alfredo Papa; Veronica Ojetti; Alfredo Pastorelli; Simona Di Caro; G Zannoni; Pasquale De Sole; Giovanni Gasbarrini; antonio gasbarrini
Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa.
Scandinavian journal of gastroenterology 2001;36(3):247-50.
2001: antonio gasbarrini; Marcello Anti; Francesco Franceschi; Alessandro Armuzzi; Rodolfo Cotichini; Veronica Ojetti; Marcello Candelli; Maria Enrichetta Lippi; M Paolucci; Valerio Cicconi; Giovanni Cammarota; S Danese; Nicolò Gentiloni Silveri; C Catananti; Paolo Pola; Tommaso Stroffolini; Giovanni Gasbarrini
Prevalence of and risk factors for Helicobacter pylori infection among healthcare workers at a teaching hospital in Rome: the Catholic University Epidemiological Study.
European journal of gastroenterology & hepatology 2001;13(2):185-9.
2001: Marcello Anti; Alessandro Armuzzi; S Morini; E Iascone; Giulia Pignataro; C Coco; R Lorenzetti; M Paolucci; Marcello Covino; A Gasbarrini; F Vecchio; Giovanni Gasbarrini
Severe imbalance of cell proliferation and apoptosis in the left colon and in the rectosigmoid tract in subjects with a history of large adenomas.
Gut 2001;48(2):238-46.
2001: Alessandro Armuzzi; Filippo Cremonini; Francesco Bartolozzi; Filippo Canducci; Marcello Candelli; Veronica Ojetti; Giovanni Cammarota; Marcello Anti; Antonino De Lorenzo; Paolo Pola; Giovanni Gasbarrini; antonio gasbarrini
The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy.
Alimentary pharmacology & therapeutics 2001;15(2):163-9.
2001: Filippo Cremonini; Filippo Canducci; Simona Di Caro; Luca Santarelli; Alessandro Armuzzi; Giovanni Gasbarrini; antonio gasbarrini
Helicobacter pylori treatment: a role for probiotics?
Digestive diseases (Basel, Switzerland) 2001;19(2):144-7.
2001: Alessandro Armuzzi; Filippo Cremonini; Veronica Ojetti; Francesco Bartolozzi; Filippo Canducci; Marcello Candelli; Luca Santarelli; Giovanni Cammarota; Antonino De Lorenzo; Paolo Pola; Giovanni Gasbarrini; antonio gasbarrini
Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study.
Digestion 2001;63(1):1-7.
2000: Cristiana Di Campli; R Nocente; G Costamagna; Nicola Gentiloni; Roberto Burioni; Jian Wu; Alessandro Armuzzi; Mark A Zern; Giovanni Gasbarrini; antonio gasbarrini
No evidence of Helicobacter pylori sequences in pancreatic juices of patients affected by chronic pancreatitis.
International journal of pancreatology : official journal of the International Association of Pancreatology 2000;28(3):181-5.
2000: Filippo Canducci; Alessandro Armuzzi; Filippo Cremonini; Giovanni Cammarota; Francesco Bartolozzi; Paolo Pola; Giovanni Gasbarrini; antonio gasbarrini
A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates.
Alimentary pharmacology & therapeutics 2000;14(12):1625-9.
2000: Giovanni Cammarota; Rossella Cianci; Oreste Cannizzaro; Lucio Cuoco; Giuseppe Alessandro Pirozzi; antonio gasbarrini; Alessandro Armuzzi; Maria Assunta Zocco; Luca Santarelli; Fabiola Arancio; Giovanni Gasbarrini
Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection.
Alimentary pharmacology & therapeutics 2000;14(10):1339-43.
2000: Alessandro Armuzzi; Stefania Marcoccia; Maria Assunta Zocco; A De Lorenzo; Antonio Grieco; Paolo Tondi; P Pola; Giovanni Gasbarrini; A Gasbarrini
Non-Invasive assessment of human hepatic mitochondrial function through the 13C-methionine breath test.
Scandinavian journal of gastroenterology 2000;35(6):650-3.
2000: A Gasbarrini; Veronica Ojetti; Dario Pitocco; Alessandro Armuzzi; Nicolò Gentiloni Silveri; Paolo Pola; giovanni ghirlanda; G Gasbarrini
Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus.
Scandinavian journal of gastroenterology 2000;35(3):260-3.
2000: antonio gasbarrini; Veronica Ojetti; Alessandro Armuzzi; G Branca; Filippo Canducci; E S Torre; Marcello Candelli; Alfredo Pastorelli; Marcello Anti; Giuseppe Fedeli; G Fadda; Paolo Pola; Giovanni Gasbarrini
Efficacy of a multistep strategy for Helicobacter pylori eradication.
Alimentary pharmacology & therapeutics 2000;14(1):79-83.
2000: Giovanni Cammarota; Oreste Cannizzaro; Veronica Ojetti; Rossella Cianci; Alfredo Pastorelli; Alessandro Armuzzi; Nicola Gentiloni; antonio gasbarrini; Giuseppe Alessandro Pirozzi; Giovanni Gasbarrini
Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection.
Alimentary pharmacology & therapeutics 2000;14(1):73-7.
1999: antonio gasbarrini; F Cremonini; Alessandro Armuzzi; Veronica Ojetti; Marcello Candelli; Cristiana Di Campli; E Sanz Torre; Roberto Pola; Giovanni Gasbarrini; Paolo Pola
The role of Helicobacter pylori in cardiovascular and cerebrovascular diseases.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 1999;50(5):735-42.
1999: Giovanni Cammarota; Oreste Cannizzaro; Rossella Cianci; Alessandro Armuzzi; antonio gasbarrini; Alfredo Pastorelli; Alfredo Papa; Giovanni Gasbarrini
Six-day or seven-day regimens with ranitidine bismuth citrate plus high-dose clarithromycin and tinidazole are both effective against Helicobacter pylori infection.
Digestive diseases and sciences 1999;44(12):2386-9.
1999: A Gasbarrini; F Franceschi; Alessandro Armuzzi; Veronica Ojetti; Marcello Candelli; E S Torre; A De Lorenzo; Marcello Anti; S Pretolani; Giovanni Gasbarrini
Extradigestive manifestations of Helicobacter pylori gastric infection.
Gut 1999;45 Suppl 1():I9-I12.
1999: antonio gasbarrini; Veronica Ojetti; Dario Pitocco; F Franceschi; Marcello Candelli; E S Torre; M Gabrielli; Giovanni Cammarota; Alessandro Armuzzi; Roberto Pola; Paolo Pola; giovanni ghirlanda; Giovanni Gasbarrini
Insulin-dependent diabetes mellitus affects eradication rate of Helicobacter pylori infection.
European journal of gastroenterology & hepatology 1999;11(7):713-6.
1999: Giovanni Cammarota; Alfredo Papa; Rossella Cianci; Oreste Cannizzaro; Alessandro Armuzzi; antonio gasbarrini; Giovanni Addolorato; Giovanni Gasbarrini
Three-day antibiotic therapy with azithromycin and tinidazole plus lansoprazole or pantoprazole to cure Helicobacter pylori infection: a pilot study.
European journal of gastroenterology & hepatology 1999;11(3):247-50.
1998: Marcello Anti; Alessandro Armuzzi; G Gasbarrini
Epithelial cell turnover and apoptosis.
Italian journal of gastroenterology and hepatology 1998;30 Suppl 3():S276-8.
1998: Giovanni Gasbarrini; P Malfertheiner; M Deltenre; Francis Mégraud; C O'Morain; J Pajares-García; Mario Quina; G Bianchi Porro; A Gasbarrini; F Franceschi; Alessandro Armuzzi; Giovanni Cammarota; Marcello Anti; S Pretolani
New concepts concerning management of Helicobacter pylori infection: 2 years after the Maastricht Consensus Report.
Italian journal of gastroenterology and hepatology 1998;30 Suppl 3():S244-7.
1998: Marcello Anti; Alessandro Armuzzi; A Gasbarrini; Giovanni Gasbarrini
Importance of changes in epithelial cell turnover during Helicobacter pylori infection in gastric carcinogenesis.
Gut 1998;43 Suppl 1():S27-32.
1998: Giovanni Cammarota; Oreste Cannizzaro; A Tursi; Alfredo Papa; antonio gasbarrini; Lucio Cuoco; R Cianei; Alessandro Armuzzi; Paolo Fedeli; Giuseppe Fedeli; Giovanni Gasbarrini
One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin.
Alimentary pharmacology & therapeutics 1998;12(6):539-43.
1998: Marcello Anti; Giulia Pignataro; Alessandro Armuzzi; A Valenti; E Iascone; R Marmo; A Lamazza; A R Pretaroli; V Pace; P Leo; A Castelli; Giovanni Gasbarrini
Water supplementation enhances the effect of high-fiber diet on stool frequency and laxative consumption in adult patients with functional constipation.
Hepato-gastroenterology 1998;45(21):727-32.
1998: Marcello Anti; Alessandro Armuzzi; E Iascone; A Valenti; Maria Enrichetta Lippi; Marcello Covino; F M Vecchio; Francesco Pierconti; A Buzzi; Giulia Pignataro; Francesca Bonvicini; Giovanni Gasbarrini
Epithelial-cell apoptosis and proliferation in Helicobacter pylori-related chronic gastritis.
Italian journal of gastroenterology and hepatology 1998;30(2):153-9.
1997: S Pretolani; Tommaso Stroffolini; Maria Rapicetta; Francesca Bonvicini; Lorenzo Baldini; F Mègraud; GC Ghironzi; F Sampogna; Umbertina Villano; F Cecchetti; G Giulianelli; ML Stefanelli; Alessandro Armuzzi; F Miglio; Giovanni Gasbarrini
Seroprevalence of hepatitis A virus and Helicobacter pylori infections in the general population of a developed European country (the San Marino study): evidence for similar pattern of spread.
European journal of gastroenterology & hepatology 1997;9(11):1081-4.
1997: Francesca Bonvicini; Lorenzo Baldini; S Pretolani; Natale Figura; Gianfranco Epifanio; Alessandro Armuzzi; F Miglio; Giovanni Gasbarrini
Anti-CagA antibodies are associated with atrophic gastritis in a population at high gastric cancer risk: a morphometric study by computerized image analysis.
Italian journal of gastroenterology and hepatology 1997;29(5):409-14.
1995: Giovanni Cammarota; A Tursi; Massimo Montalto; Alfredo Papa; G Branca; F M Vecchio; C Renzi; A Verzí; Alessandro Armuzzi; S Pretolani
Prevention and treatment of low-grade B-cell primary gastric lymphoma by anti-H. pylori therapy.
Journal of clinical gastroenterology 1995;21(2):118-22.